The Merz Group is a leading mid-sized European specialty pharmaceutical group of companies. The Group’s prescription research platform is located in Frankfurt, Germany with core competencies in central nervous system (CNS) and dermatology.
The Merz Group is focused on pharmaceuticals for the treatment of neurological and psychiatric disorders and is a leader in the field of Alzheimer's research.
The company also researches and develops over-the-counter products for the prevention of health problems and the preservation of fitness and well-being.